I think it’s important to do via a path that will work with frameworks of developed world countries.

Used could be first done for more easy situation to evaluate: a person dying of organ impairment on the transplant waitlist. And so and so on.

But, yeah, perhaps someone will start in jurisdictions like you mentioned.

I will try to read your points and references and give you my perspective on that.

1 Like

Thank you @scta123 , much appreciated!

This is big:

  1. Styled after the success of DARPA - that e.g. was behind inventions such as the Internet and GPS… ARPA-H is a new bold, ultra ambitious federal funding agency with the goal of doing the same for human health!

  2. This is transplantation of whole human eyes, including the optical nerve - which is part of the brain. So in addition to its value in itself, this could be a very helpful catalyst to surgically reconnect nerves and CNS.

As ARPA-H says itself:

“The success of the program extends far beyond eye transplants and vision restoration. Techniques in microsurgery and gene or cell-based therapies for nerve regeneration may have the potential to be applied to other types of nervous system damage, including spinal cord injury. By starting with the eye’s nerves, the outputs of THEA could improve research into brain repair as well.”

And

“While it has been nearly 60 years since the first successful human heart transplant, we have not been able to use similar approaches to restore a person’s sight, and that’s what makes this an ARPA-hard problem to solve,” said ARPA-H Director Renee Wegrzyn, Ph.D. “Through THEA, we’re seeking to develop the next breakthroughs in transplantation, preservation, and neuroscience to address the challenge

2 Likes

5 Likes

Longevity and Tissue Replacement with Professor Jean Hébert

2 Likes

Surgeons in Boston have transplanted a kidney from a genetically engineered pig into an ailing 62-year-old man, the first procedure of its kind. If successful, the breakthrough offers hope to hundreds of thousands of Americans whose kidneys have failed.

So far, the signs are promising.

Kidneys remove waste products and excess fluid from the blood. The new kidney began producing urine shortly after the surgery last weekend

5 Likes

As my sister-in-law is waiting for a kidney, this could be life-saving news. Now the question is how long until everyone is approved for one/can get one?

1 Like

For the first time, scientists are attempting to grow a new, miniature liver inside of a person. It sounds like science fiction; in fact, the idea was the plot of a Grey’s Anatomy episode that aired in 2018. Now, biotech company LyGenesis is trying to turn the concept into reality.

Today, LyGenesis announced that an initial volunteer has received an injection of donor cells to turn one of their lymph nodes into a second liver. The procedure was carried out in Houston on March 25 as part of a clinical trial that will test the experimental treatment in 12 adults with end-stage liver disease.

Full article: This Bag of Cells Could Grow New Livers Inside of People (Wired)

3 Likes

Hi @scta123 - would really love to hear your perspectives here when you have some time!

Some more support for how it could reset the clock to young age


And

And

3 Likes

2 Likes

Full body replacement is really a non starter. Cryo worries me in so many ways. I am unsure i would want the experience of being revived and living as a damaged entity although there have been people who have got very cold and revived.

OTOH i think i understand what to do to mitigate time linked deterioration.

1 Like

Isn’t that what we all (those above 15-25 or so) are compared to our younger selves?

1 Like

True. There are always questions of how damaged, however.

1 Like

What organs can be replaced by machines? Benefits, side effects, over organic transplant? BiVACOR artificial heart:

Professor Chris Hayward, from the Victor Chang Cardiac Research Institute, said the BiVACOR heart ushered in “a whole new ball game for heart transplants.”

“Within the next decade we will see the artificial heart becoming the alternative for patients who are unable to wait for a donor heart or when a donor heart is simply not available,” said Hayward, who is overseeing the Australian patient’s recovery and was involved in preparing the device for clinical trials.

2 Likes

By the editor of the piece:


See more discussion here

https://x.com/antonioregalado/status/1904589199367430305?

1 Like

Disease Research Acceleration

Currently, drug development is extremely inefficient (poor predictive models, many failed drugs), costly (>$1B/successfully developed drug), time-consuming (15+ years from in silico to drug approval), and risk-averse (hard to get investments for new strategies or new indications that don’t yet have any approved treatments)

  • With non-sentient human models, we could directly test interventions for nearly all non-neurological diseases, potentially accelerating cure development by decades
  • This represents an enormous multiplier on existing medical research investments. Costs for drug development could drop 1, potentially 2 orders of magnitude. Time to approval could shorten to a year.

(Maybe for another thread)

Hmm, I wonder about the usefulness of discussing these topics with humans here etc, AI’s are already about as smart as humans or smarter (e.g Gemini 2.5 Pro), or very soon are, like this year. Basically what everyone is doing here is soon replaced, and AGI/LEV/ASI etc maybe not soon after, in the good scenario.

All evidence points to this in the next few years? Or am I wrong?

Might just chill back and drink a diet coke (or pepsi) and rewatch this old documentary…

1 Like